Skip to content

Meet us at COP31Read more

Nanobiotix SA Sustainability Reports

Nanobiotix S.A. is a clinical-stage biotechnology company that develops physics-based therapeutic nanoparticles designed to safely enhance the efficacy of radiation therapy in oncology. The company aims to improve cancer treatment outcomes at the cellular level across various solid tumor indications.

Sector: Professional & technical services

Country: France

Exchange: Euronext Paris

LEI: 969500667RSYIH8YL895

FIGI: BBG001V0G683

19 reports from 2012 to 2025